Position in PLRX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$651,806
-$681,216 QoQ
Shares Held
571,760
-46.0% QoQ
Ownership
0.923%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#22
of 86 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PLRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026UBS Group AG holds $8,751,270,183 across 562 Biotechnology names. PLRX ranks #279 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
5,450,825 | $1,020,369,609 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
17,466,641 | $618,144,423 | |
| 3 | PTGX |
Protagonist Therapeutics, Inc
|
3,399,221 | $416,676,508 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
712,259 | $353,800,411 | |
| 5 | MRNA |
Moderna, Inc.
|
4,463,211 | $312,558,664 | |
| 6 | INSM |
INSMED Inc
|
2,584,446 | $275,553,630 | |
| 7 | ABVX |
Abivax S.A.
|
1,844,918 | $245,853,771 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
401,708 | $215,697,109 |
All Filings in PLRX
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $651,806 | 571,760 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $1,333,022 | 1,057,954 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $1,296,390 | 1,062,615 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $1,956,584 | 1,322,017 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $3,070,004 | 2,646,556 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $3,571,486 | 2,645,546 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $8,274,460 | 628,281 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $2,581,752 | 230,308 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,636,171 | 152,202 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $5,439,453 | 365,064 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $6,196,753 | 342,173 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $4,695,741 | 270,804 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $54,793 | 3,024 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $387,295 | 14,560 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $104,284 | 5,395 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $137,873 | 6,600 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $28,330 | 3,537 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $20,938 | 2,987 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $139,333 | 10,321 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $32,577 | 1,930 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $40,680 | 1,397 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $35,239 | 896 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $31,330 | 1,379 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $56,851 | 2,510 | Shares | Defined | 2020-11-12 | |
| No filing history on record for this holder in this stock. | ||||||